| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,425 |
4,904 |
$228K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,242 |
962 |
$82K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,019 |
806 |
$34K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,843 |
726 |
$19K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
273 |
248 |
$15K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
443 |
386 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
778 |
605 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
998 |
821 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
127 |
92 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
20 |
16 |
$529.95 |
| 90658 |
|
13 |
12 |
$190.90 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
13 |
12 |
$135.29 |
| 94760 |
|
26 |
13 |
$79.10 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
17 |
14 |
$44.68 |
| 81003 |
|
18 |
13 |
$28.59 |
| 99051 |
|
1,255 |
941 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
16 |
13 |
$0.00 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
26 |
25 |
$0.00 |